news videos images websites

Baxter International Company News

Thu, 03 Nov 2016 07:52:49 GMT

Baxter starts phase 3 trial of new therapy for acute kidney injury  -  Pharmaceutical Business Review
Baxter acute therapies medical director Farah Ali said: “One potential obstacle in delivering effective CRRT occurs when blood flow through the circuit is slowed or completely stopped by blood clots. “Extending the life of the extracorporeal circuit ...
Thu, 03 Nov 2016 06:20:04 GMT
Healthcare Mover to Target: Baxter International Inc. (NYSE:BAX) , Insulet Corporation (NASDAQ:PODD)  -  Is stories
On 11/2/2016, Baxter International Inc. (NYSE:BAX) dropped -0.32% and ended at $46.74. The stock's market capitalization arrived at $25.42B and total traded volume was 5.65 million shares. The stock has a 52-week highest price of $50.16 and its 52-week ...
Wed, 02 Nov 2016 21:16:30 GMT

Filmmaker, Defying Threats, to Air Documentary Alleging Donald Trump Made Life in Scottish Town 'Hell Over The Years'  -  PEOPLE.com
“I think it's a very important story,” Baxter says. “Donald Trump's reaction, of course, is to take some time off from campaigning to issue a legal threat and we're all used to that kind of behavior from him. He has access to lawyers and he uses that ...
Wed, 02 Nov 2016 20:30:51 GMT
Is this Large Market Cap Stock target price reasonable for Baxter International Inc. (NYSE:BAX)?  -  The Daily Leicester
The company in question is, Baxter International Inc. (NYSE:BAX) currently with a stock price of 46.89 (-1.47% today). The market cap for Baxter International Inc. is 26427.67, and is in the sector Healthcare, and Medical Instruments & Supplies industry.
Wed, 02 Nov 2016 19:44:23 GMT
Equities Analysts Issue Forecasts for Baxter International Inc.'s Q1 2018 Earnings (BAX)  -  BBNS
Baxter International logo Baxter International Inc. (NYSE:BAX) – Investment analysts at Leerink Swann issued their Q1 2018 earnings per share (EPS) estimates for Baxter International in a report released on Sunday. Leerink Swann analyst D. Antalffy ...
Wed, 02 Nov 2016 18:21:49 GMT

Baxter International Inc. (NYSE:BAX) Analyst Estimates And Rating  -  The Independent Republic
Baxter International Inc. (NYSE:BAX) stock is presently standing at about $46.89 and lots of equity research firms seem to have a target price set on the stock. The median one-year price target of 12 analysts covering the company is $53.00, which ...
Wed, 02 Nov 2016 17:47:30 GMT
Global Hemophilia A Market Report 2015-2019 – Analysis, Technologies & Forecasts – Key Vendors: Baxter ...  -  Medgadget (blog)
MRW-LOGO9 Hemophilia A Market research report provides granular analysis of the market share, segmentation, revenue forecasts and geographic regions of the market. Hemophilia A market report 2015-2019 focuses on the major drivers and restraints for ...
Wed, 02 Nov 2016 17:08:05 GMT
Baxter International Inc. (NYSE:BAX) Fundamental Star Rating Report  -  CML News
This is a fundamental star rating report for Baxter International Inc. (NYSE:BAX) . The Capital Market Laboratories Star Rating is an objective, quantifiable measure of a company's operating and financial condition. Our research sits side-by-side with ...
Wed, 02 Nov 2016 16:15:12 GMT
Analyst Research Roundup: PulteGroup, Inc. (NYSE:PHM), Baxter International Inc. (NYSE:BAX)  -  TWN
At the most recent close, PulteGroup, Inc. (NYSE:PHM) tinted gains of +0.16% (+0.03 points) to US$18.63. The volume of 7.3 Million shares climbed up over an trading activity of 4.41 Million shares. EPS ratio determined by looking at last 12 month ...
Wed, 02 Nov 2016 15:51:34 GMT
Baxter International Inc. (NYSE:BAX): Sell-Side Focus  -  Transcript Daily
For the quarter ending 2016-12-31, analysts have $0.78 as the consensus EPS estimate for Baxter International Inc. (NYSE:BAX). But on or around 2017-02-07, the company is expected to post its next earnings numbers. $0.56 is the last posted EPS, which ...